Literature DB >> 16628450

Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.

Petra Yescas1, Adriana Huertas-Vazquez, María Teresa Villarreal-Molina, Astrid Rasmussen, María Teresa Tusié-Luna, Marisol López, Samuel Canizales-Quinteros, María Elisa Alonso.   

Abstract

The etiology of Alzheimer's disease (AD) is complex. To date, molecular genetic studies in several families affected with AD have identified three genes associated with highly penetrant early-onset AD: Presenilin 1 (PSEN1), Presenilin 2 (PSEN2) and beta-amyloid precursor protein (APP); and one gene (apolipoprotein E) associated with late-onset AD. Molecular analysis of the PSEN1 gene was performed by direct sequencing of genomic DNA. The possible founder effect was investigated analyzing two highly polymorphic microsatellite markers flanking the PSEN1 gene. Twelve unrelated Mexican families with early-onset AD were analyzed. The Ala431Glu mutation in exon 12 of PSEN1 was found in nine (75%) of these families, which segregated showing autosomal dominant inheritance. Because all families bearing the mutation are from the State of Jalisco (located in Western Mexico), a founder effect was hypothesized. Microsatellite haplotype analysis suggested a common ancestor in these nine kindreds. In conclusion, the Ala431Glu mutation is a prevalent cause of early-onset familial Alzheimer's disease in families from the State of Jalisco, Mexico. Genetic evidence supports that it is a founder mutation descending from a single common ancestor. These findings have important implications for prompt diagnosis and genetic counseling for Mexican patients with familial AD from Jalisco.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628450     DOI: 10.1007/s10048-006-0043-3

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  22 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  [Alzheimer's disease. Presentation of 7 cases in 3 families].

Authors:  L Gómez Valencia; E Alonso; H H Figueroa; A Escobar
Journal:  Rev Invest Clin       Date:  1986 Jul-Sep       Impact factor: 1.451

4.  Novel mutations and repeated findings of mutations in familial Alzheimer disease.

Authors:  Ulrich Finckh; Christian Kuschel; Maria Anagnostouli; Efstratios Patsouris; George V Pantes; Stylianos Gatzonis; Elisabeth Kapaki; Panagiota Davaki; Katrin Lamszus; Dimitrios Stavrou; Andreas Gal
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

5.  Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect.

Authors:  T D Bird; T H Lampe; E J Nemens; G W Miner; S M Sumi; G D Schellenberg
Journal:  Ann Neurol       Date:  1988-01       Impact factor: 10.422

6.  Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.

Authors:  C De Jonghe; M Cruts; E A Rogaeva; C Tysoe; A Singleton; H Vanderstichele; W Meschino; B Dermaut; I Vanderhoeven; H Backhovens; E Vanmechelen; C M Morris; J Hardy; D C Rubinsztein; P H St George-Hyslop; C Van Broeckhoven
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

7.  A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.

Authors:  C Tysoe; J Whittaker; J Xuereb; N J Cairns; M Cruts; C Van Broeckhoven; G Wilcock; D C Rubinsztein
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; F Paz; J Murrell; M Angel Macias; M Hill; C Kawas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  20 in total

1.  Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

Authors:  John M Ringman; David Elashoff; Daniel H Geschwind; Brian T Welsh; Karen H Gylys; Cathy Lee; Jeffrey L Cummings; Greg M Cole
Journal:  Arch Neurol       Date:  2012-06

2.  Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.

Authors:  Liana G Apostolova; Kristy S Hwang; Luis D Medina; Amity E Green; Meredith N Braskie; Rebecca A Dutton; Jeffrey Lai; Daniel H Geschwind; Jeffrey L Cummings; Paul M Thompson; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-09-23       Impact factor: 2.959

3.  Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

Authors:  John M Ringman; Luis D Medina; Meredith Braskie; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel A Macias-Islas; Jeffrey L Cummings; Susan Bookheimer
Journal:  Cereb Cortex       Date:  2010-08-20       Impact factor: 5.357

4.  The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families.

Authors:  Jill Murrell; Bernardino Ghetti; Elizabeth Cochran; Miguel Angel Macias-Islas; Luis Medina; Arousiak Varpetian; Jeffrey L Cummings; Mario F Mendez; Claudia Kawas; Helena Chui; John M Ringman
Journal:  Neurogenetics       Date:  2006-08-05       Impact factor: 2.660

Review 5.  Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.

Authors:  Irving E Vega; Laura Y Cabrera; Cassandra M Wygant; Daniel Velez-Ortiz; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.

Authors:  Erik Portelius; Ulf Andreasson; John M Ringman; Katharina Buerger; Jonny Daborg; Peder Buchhave; Oskar Hansson; Andreas Harmsen; Mikael K Gustavsson; Eric Hanse; Douglas Galasko; Harald Hampel; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Neurodegener       Date:  2010-01-14       Impact factor: 14.195

7.  Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.

Authors:  Steffan K Soosman; Nelly Joseph-Mathurin; Meredith N Braskie; Yvette M Bordelon; David Wharton; Maria Casado; Giovanni Coppola; Holly McCallum; Marc Nuwer; Pedro Coutin-Churchman; Liana G Apostolova; Tammie Benzinger; John M Ringman
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

8.  Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease.

Authors:  Mario R Cornejo-Olivas; Chang-En Yu; Pilar Mazzetti; Ignacio F Mata; Maria Meza; Saul Lindo-Samanamud; James B Leverenz; Thomas D Bird
Journal:  Neurosci Lett       Date:  2014-02-02       Impact factor: 3.046

9.  Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.

Authors:  John M Ringman; Sarah Monsell; Denise W Ng; Yan Zhou; Andy Nguyen; Giovanni Coppola; Victoria Van Berlo; Mario F Mendez; Spencer Tung; Sandra Weintraub; Marek-Marsel Mesulam; Eileen H Bigio; Darren R Gitelman; Amanda O Fisher-Hubbard; Roger L Albin; Harry V Vinters
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-17       Impact factor: 3.685

10.  Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease.

Authors:  John Matthew Ringman; Whitney Pope; Noriko Salamon
Journal:  J Neurol       Date:  2010-01-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.